DBV Technologies | DBVT - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
DBV Technologies USD 1.23B 327M 2026-03
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Insmed USD 23.11B 12.19B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
United Therapeutics USD 23B 2.19B 2026-06